Found: 30
Select item for more details and to access through your institution.
Identification of immunophenotypic signatures by clustering analysis in pediatric patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 2, p. 138, doi. 10.1002/ajh.21595
- By:
- Publication type:
- Article
A Novel t(8;14)(q24;q11) Rearranged Human Cell Line as a Model for Mechanistic and Drug Discovery Studies of NOTCH1-Independent Human T-Cell Leukemia.
- Published in:
- Cells (2073-4409), 2018, v. 7, n. 10, p. 160, doi. 10.3390/cells7100160
- By:
- Publication type:
- Article
AIEOP‐BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia.
- Published in:
- Cytometry. Part B, 2018, v. 94, n. 1, p. 82, doi. 10.1002/cyto.b.21518
- By:
- Publication type:
- Article
Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 3, p. 247, doi. 10.1002/cyto.b.21267
- By:
- Publication type:
- Article
Flow diagnostics essential code: A simple and brief format for the summary of leukemia phenotyping.
- Published in:
- Cytometry. Part B, 2014, v. 86, n. 4, p. 288, doi. 10.1002/cyto.b.21144
- By:
- Publication type:
- Article
FCM marker importance for MRD assessment in T‐cell acute lymphoblastic leukemia: An AIEOP‐BFM‐ALL‐FLOW study group report.
- Published in:
- Cytometry. Part A, 2024, v. 105, n. 1, p. 24, doi. 10.1002/cyto.a.24805
- By:
- Publication type:
- Article
CD72 is a pan‐tumor antigen associated to pediatric acute leukemia.
- Published in:
- Cytometry. Part A, 2023, v. 103, n. 12, p. 1004, doi. 10.1002/cyto.a.24790
- By:
- Publication type:
- Article
CD56, HLA‐DR, and CD45 recognize a subtype of childhood AML harboring CBFA2T3‐GLIS2 fusion transcript.
- Published in:
- Cytometry. Part A, 2021, v. 99, n. 8, p. 844, doi. 10.1002/cyto.a.24339
- By:
- Publication type:
- Article
Low-Blood Lymphocyte Number and Lymphocyte Decline as Key Factors in COPD Outcomes: A Longitudinal Cohort Study.
- Published in:
- Respiration, 2021, v. 100, n. 7, p. 618, doi. 10.1159/000515180
- By:
- Publication type:
- Article
Prognostic Role of Minimal Disseminated Disease and NOTCH1/FBXW7 Mutational Status in Children with Lymphoblastic Lymphoma: The AIEOP Experience.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 9, p. 1594, doi. 10.3390/diagnostics11091594
- By:
- Publication type:
- Article
Relative expansion of CD19‐negative very‐early normal B‐cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR‐T cell therapy: implications for flow cytometric detection of minimal residual disease
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. 602, doi. 10.1111/bjh.17382
- By:
- Publication type:
- Article
Minimal residual disease analysis in childhood mature B‐cell leukaemia/lymphoma treated with AIEOP LNH‐97 protocol with/without anti‐CD20 administration.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 3, p. e108, doi. 10.1111/bjh.16531
- By:
- Publication type:
- Article
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP‐BFM ALL protocols.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 5, p. 705, doi. 10.1111/bjh.15449
- By:
- Publication type:
- Article
Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 5, p. 680, doi. 10.1111/bjh.15086
- By:
- Publication type:
- Article
Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP- AML 2002/01 study protocol.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 1, p. 116, doi. 10.1111/bjh.14523
- By:
- Publication type:
- Article
NUP214–ABL1 fusion in childhood T‐ALL.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 9, p. 1, doi. 10.1002/pbc.29643
- By:
- Publication type:
- Article
Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high‐risk first relapse B‐cell precursor acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 8, p. 1, doi. 10.1002/pbc.29715
- By:
- Publication type:
- Article
Next‐generation sequencing of PTEN mutations for monitoring minimal residual disease in T‐cell acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2020, v. 67, n. 1, p. N.PAG, doi. 10.1002/pbc.28025
- By:
- Publication type:
- Article
Next-generation sequencing of PTEN mutations for monitoring minimal residual disease in T-cell acute lymphoblastic leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Case of T-cell Acute Lymphoblastic Leukemia Relapsed As Myeloid Acute Leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Detection and role of minimal disseminated disease in children with lymphoblastic lymphoma: The AIEOP experience.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients.
- Published in:
- BMC Infectious Diseases, 2007, v. 7, n. 1, p. 28, doi. 10.1186/1471-2334-7-28
- By:
- Publication type:
- Article
Spinal cord injury without radiographic abnormalities.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Advanced pediatric myelodysplastic syndromes: Can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
- Published in:
- Pediatric Blood & Cancer, 2009, v. 52, n. 3, p. 357, doi. 10.1002/pbc.21874
- By:
- Publication type:
- Article
Leukemia blast cell identification.
- Published in:
- WIREs: Data Mining & Knowledge Discovery, 2015, v. 5, n. 2, p. 74, doi. 10.1002/widm.1146
- By:
- Publication type:
- Article
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD).
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2475, doi. 10.3390/cancers14102475
- By:
- Publication type:
- Article
An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6148, doi. 10.3390/cancers13236148
- By:
- Publication type:
- Article
NFATc1 and NFATc2 transcription factors drive the resistance to glucocorticoids in Acute Lymphoblastic Leukemia pediatric patients.
- Published in:
- Italian Journal of Anatomy & Embryology / Archivio Italiano di Anatomia Ed Embriologia, 2023, p. 93
- By:
- Publication type:
- Article
Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus.
- Published in:
- Antioxidants, 2023, v. 12, n. 3, p. 625, doi. 10.3390/antiox12030625
- By:
- Publication type:
- Article